# A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

> **NCT00911937** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 963 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Fesoterodine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00911937
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 963 (ACTUAL)
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911937, "A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00911937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*